Teladoc Health Reports Fourth Quarter and Full Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Teladoc (TDOC) Shares Down 7% Following Q4 Results and Mixed Outlook
February 22, 2022 5:37 PM ESTTeladoc (NYSE: TDOC) shares were trading around 7% lower after-hours despite the company's reported Q4 results, with EPS of ($0.07) coming in better than the Street estimate of ($0.56). Revenue grew 45% year-over-year to $554.2 million, compared to the Street estimate of $546.6 million. Access fees and visit fee revenues grew 51% and... More
Teladoc (TDOC) Tops Q4 EPS, Revenues; Provides Mixed Outlook
February 22, 2022 4:13 PM ESTTeladoc (NYSE: TDOC) reported Q4 EPS of ($0.07), $0.49 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $554.2 million versus the consensus estimate of $546.6 million.
GUIDANCE:
Teladoc sees FY2022 revenue of $2.55-2.65 billion, versus the consensus of $2.57... More
